Teva Announces Agreement to Divest Teva-Takeda, its Business Venture in Japan
Teva entered into an agreement with JKI Co., Ltd. (“JKI”) established by the fund managed and operated by private equity…
Pharmaceuticals, Biotechnology and Life Sciences
Teva entered into an agreement with JKI Co., Ltd. (“JKI”) established by the fund managed and operated by private equity…
LA JOLLA, Calif., Dec. 05, 2024 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market…
RICHMOND, Calif., Dec. 05, 2024 (GLOBE NEWSWIRE) — BioAge Labs (Nasdaq: BIOA) (“BioAge”, “the Company”), a clinical-stage biopharmaceutical company developing…
WILMETTE, Ill., Dec. 05, 2024 (GLOBE NEWSWIRE) — Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biotechnology company focused on developing…
Underwriters’ full exercise of option brings gross proceeds to $862.5 millionREDWOOD CITY, Calif., Dec. 05, 2024 (GLOBE NEWSWIRE) — Revolution…
BERKELEY HEIGHTS, N.J., Dec. 05, 2024 (GLOBE NEWSWIRE) — Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or the “Company”),…
Article 223-16 of general regulation of French Autorité des Marchés Financiers Listing market: Euronext Paris (Market segment C – ISIN Code:…
Data Support Start of First Pivotal Trial for an Off-the-Shelf, Allogeneic CD7-Targeted CAR-T Cell Therapy in Pediatric and Adult PatientsST.…
WARREN, N.J., Dec. 05, 2024 (GLOBE NEWSWIRE) — Dr. Ryan Saadi, CEO of Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings…
Measure your biological age with cutting-edge epigenetic testing, 85% more affordable than competitors, bringing advanced longevity science within reach for…